An experimental gene therapy for sickle cell disease restored blood cells to their normal shape and eliminated severe pain crises for years after treatment, a multicenter study has found.
A single dose restored blood cells to their normal shape and eliminated the most serious complication of sickle cell disease for at least three years in some pa
According to a study, a single dose restored blood cells to their normal shape and eliminated the most serious complication of sickle cell disease for at least three years in some patients.
According to a study, a single dose restored blood cells to their normal shape and eliminated the most serious complication of sickle cell disease for at least three years in some patients.
According to a study, a single dose restored blood cells to their normal shape and eliminated the most serious complication of sickle cell disease for at least